Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CSKH: close at HOD; extremely big volume
Tomorrow: breakout
CSKH: BREAKOUT alert!!!
.044 BREAKOUT!!!!!
RT .042 195K; CSKH RISING
CSKH: RT .040
CTSO opens at .135
Goodmorning. CTSO just opened at .135
CTSO made it on breakout boards
CTSO: crossed the 200MA,closed at HOD; extreme high volume; 100% buy
http://www.barchart.com/opinions/stocks/CTSO
TA extremely positive, new presentation, new article on biomed reports, patient enrollment almost completed... Breakout coming!
CSKH:Reiterates 2010 15M dollar Revenue Guidance
http://ih.advfn.com/p.php?pid=nmona&article=44746391&symbol=CSKH
great news indeed!!!
CTSO: closed at HOD yesterday; crossed the 200MA; extreme high volume!!!
100% buy: http://www.barchart.com/opinions/stocks/CTSO
Article from biomed reports:
"Monday, investors in Cytosorbents (OTC: CTSO) saw an increase of 13.64% on volume of 2.95 million. This adds to Friday’s gain of over 21% on nearly 3.5 million volume. These two days alone had more volume than the past seven days combined. The question now becomes: What’s triggering this renewed interest in the company?
In my mid-September penny stock pick for BioMedReports, I notified readers that Cytosorbents was nearing several key milestones including successful trial completion, partnership talks and ultimately CE Mark approval. On September 27, Cytosorbents announced the achievement of an ISO 13485 Certification. This certification is extremely beneficial to the company as Dr. Chan explained:
“Of the possible options, Full Quality Systems certification is the most stringent and efficient route to CE Mark approval for CytoSorb™ and other future CytoSorbents products. When coupled with CE Mark approval, ISO 13485 certification will allow CytoSorbents to commercialize its products in the E.U. market and other countries that recognize the ISO 13485 and CE Mark standards."
This suggests that the trial is going well and the company is taking the steps to expedite the CE Mark approval process upon completion.
In other news, Cytosorbents announced on Monday that the company was selected to present at the prestigious 2010 AdvaMed MedTech Conference in Washington D.C. on October 20. This will be another great opportunity for Cytosorbents to update the investment community on the company’s progress. In my last update, the trial was nearly 80% complete. Nearly a month later, (based on historical enrollment rates) we can expect that number to increase to about 85%.
From a technical standpoint, the stock has completed a major breakout on a number of fronts. First, the ISO 13485 certification announcement pushed the stock price out of a 1.5 month bullish pennant which had kept the price at $.09 or below. Second, and more importantly, was Friday’s move above the $.10 mark.
This is the first time in about five months that the price has closed above this level. In addition, it solidifies the company’s financial position moving forward as it allows the company to utilize its financing arrangement (if necessary) with Lincoln Park Capital completed on May 10. Today, price was able to break through the 200-day moving average at $.122. This inflection point signals bulls are in control and price has room to run significantly.
Both the fundamentals and the technicals are pointing to a sustained move higher.
With the trial nearing completion, investors can expect increased interest and volatility.
However, if there is one mantra an investor should heed: Volume Precedes Price!"
http://biomedreports.com/2010101257765/pump-up-the-volume-cytosorbents-breaking-out.html
CSKH: Nice close at .038. Green candlestick
CTSO: Close at HOD; crossed the 200MA; extreme high volume; tomorrow breakout!!!
Close at HOD; crossed the 200MA; extreme high volume; tomorrow breakout!!!
Interesting statement:
"CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company using blood purification to treat life-threatening illnesses, was chosen to present at the AdvaMed 2010 MedTech Conference at the Walter E. Washington Convention Center in Washington, D.C. next week. Dr. Phillip Chan, Chief Executive Officer, will speak Wednesday, October 20, 2010 at 10:10AM EDT in Room 204a.
http://www.advamed2010.com/go.cfm?do=Page.View&pid=80
Following the meeting, the presentation will be made available on the company's investor relations website:
http://www.cytosorbents.com/invest.htm
With all the presentations and investor conferences the past few months, none has been made available before ... sounds like an announcement is forthcoming! "
source yahoo
author: miloinla
EXTERMINATION deadline of the 200MA and resistance of .122 at power hour!
CTSO:huge volume;breaking the 200MA (set at 0.122)
CTSO: about to break the 200MA at 0.122
Breakout time soon. CSKH: RT.038
They've an institutional holder:
Pacific West Financial Consultants, Inc
link: http://finance.yahoo.com/q/mh?s=AMST.PK+Major+Holders
BREAKOUT ALERT!
CTSO: getting ready for a breakout!
CSKH: "At just two times this year’s revenue shares should be in the to mid-$.20 range." 10-bagger alert
http://www.joenoelstocks.com/stocks-covered/biomagnetics-diagnostics-bmgp/kblb-joe-noel-2/
CSKH: "shares are preparing for major run"
With financing back into the solar industry, a very full pipeline of business, several large projects currently underway, and a cleaned up balance sheet with virtually all convertible debt having been eliminated, we think the shares are preparing for a major run higher. At just two times this year’s revenue shares should be in the to mid-$.20 range.
http://www.joenoelstocks.com/stocks-covered/biomagnetics-diagnostics-bmgp/kblb-joe-noel-2/
"With financing back into the solar industry, a very full pipeline of business, several large projects currently underway, and a cleaned up balance sheet with virtually all convertible debt having been eliminated, we think the shares are preparing for a major run higher."
JoeNoel
http://www.joenoelstocks.com/stocks-covered/biomagnetics-diagnostics-bmgp/kblb-joe-noel-2/
Big run is coming!!!
I agree on that. CTSO has everything which is needed: news, news that is coming, and a TA which screams "buy me"
BMGI #10 in breakout boards!
I expect some news from EVFN as well very shortly. It is not over yet. If good news head to evfn: this could go x100
Indeed.Don't worry guys, this could be a potential Nasdaq company in 3 years. Did everybody hear about the water pollution in Hungary? Imagine that this would happen with our drinking water?!! Who could help us? Indeed solarbook water and power corp.
!DARE TO THINK BIG!
Thank you for the TA. Goooo CTSO
Technical analysis all scream "buy".
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=55352540
http://www.barchart.com/opinions/stocks/CTSO
I don't think a buyout will happen. The CEO is too proud of his realizations and as a shareholder I would like support him to keep this company away from a buyout. Watch it on the longterm, like 3-5 years. This company could be worth dollars/share.
I know it was already for sale in Korea.But I thought this meant that the sales of Stemmix were starting in the US. I still think that this is the case.
How about the CTSO chart?
Hopefully news for AAVG next week and a strong volume to break this solid resistance at 0.013.
CTSO: 100% screaming to buy: http://www.barchart.com/opinions/stocks/CTSO
Keep an eye on AAVG.There is a huge accumulation at .010
There could be acquisition news announced the coming week (if not, then certainly in the near future). Ludlow capital gave it a target of .08-.10$/share, so with acquisition news being announced I can see a +200% rise.